These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

639 related items for PubMed ID: 16569521

  • 1. Mucosal features and granulocyte-monocyte-apheresis in steroid-dependent/refractory ulcerative colitis.
    D'Ovidio V, Aratari A, Viscido A, Marcheggiano A, Papi C, Capurso L, Caprilli R.
    Dig Liver Dis; 2006 Jun; 38(6):389-94. PubMed ID: 16569521
    [Abstract] [Full Text] [Related]

  • 2. In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients.
    Tanaka T, Okanobu H, Yoshimi S, Murakami E, Kogame A, Imagawa H, Numata Y, Kuga Y, Moriya T, Ohya T, Kajiyama G.
    Dig Liver Dis; 2008 Sep; 40(9):731-6. PubMed ID: 18387860
    [Abstract] [Full Text] [Related]

  • 3. A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis.
    Sands BE, Sandborn WJ, Feagan B, Löfberg R, Hibi T, Wang T, Gustofson LM, Wong CJ, Vandervoort MK, Hanauer S, Adacolumn Study Group.
    Gastroenterology; 2008 Aug; 135(2):400-9. PubMed ID: 18602921
    [Abstract] [Full Text] [Related]

  • 4. Granulocyte and monocyte adsorptive apheresis in the treatment of active distal ulcerative colitis: a prospective, pilot study.
    Yamamoto T, Umegae S, Kitagawa T, Yasuda Y, Yamada Y, Takahashi D, Mukumoto M, Nishimura N, Yasue K, Matsumoto K.
    Aliment Pharmacol Ther; 2004 Oct 01; 20(7):783-92. PubMed ID: 15379839
    [Abstract] [Full Text] [Related]

  • 5. Factors affecting clinical and endoscopic efficacies of selective leucocytapheresis for ulcerative colitis.
    Yamamoto T, Saniabadi AR, Maruyama Y, Umegae S, Matsumoto K.
    Dig Liver Dis; 2007 Jul 01; 39(7):626-33. PubMed ID: 17532273
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Treating ulcerative colitis by Adacolumn therapeutic leucocytapheresis: clinical efficacy and safety based on surveillance of 656 patients in 53 centres in Japan.
    Hibi T, Sameshima Y, Sekiguchi Y, Hisatome Y, Maruyama F, Moriwaki K, Shima C, Saniabadi AR, Matsumoto T.
    Dig Liver Dis; 2009 Aug 01; 41(8):570-7. PubMed ID: 19211314
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of the efficacy of granulocyte and monocyte/macrophage adsorptive apheresis and leukocytapheresis in active ulcerative colitis patients: a prospective randomized study.
    Sakata Y, Iwakiri R, Amemori S, Yamaguchi K, Fujise T, Otani H, Shimoda R, Tsunada S, Sakata H, Ikeda Y, Ando T, Nakafusa Y, Fujimoto K.
    Eur J Gastroenterol Hepatol; 2008 Jul 01; 20(7):629-33. PubMed ID: 18679064
    [Abstract] [Full Text] [Related]

  • 11. Granulocyte, monocyte/macrophage apheresis for inflammatory bowel disease: the first 100 patients treated in Scandinavia.
    Ljung T, Thomsen OØ, Vatn M, Karlén P, Karlsen LN, Tysk C, Nilsson SU, Kilander A, Gillberg R, Grip O, Lindgren S, Befrits R, Löfberg R.
    Scand J Gastroenterol; 2007 Feb 01; 42(2):221-7. PubMed ID: 17327942
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of granulocyte and monocyte adsorption apheresis for ulcerative colitis: a meta-analysis.
    Yoshino T, Nakase H, Minami N, Yamada S, Matsuura M, Yazumi S, Chiba T.
    Dig Liver Dis; 2014 Mar 01; 46(3):219-26. PubMed ID: 24268950
    [Abstract] [Full Text] [Related]

  • 15. Suppression of inflammatory cytokine secretion by granulocyte/monocyte adsorptive apheresis in active ulcerative colitis.
    Andoh A, Tsujikawa T, Inatomi O, Deguchi Y, Hata K, Kitoh K, Sasaki M, Mitsuyama K, Fujiyama Y.
    Ther Apher Dial; 2005 Apr 01; 9(2):123-7. PubMed ID: 15828923
    [Abstract] [Full Text] [Related]

  • 16. Sustained remission after steroids and leukocytapheresis induced response in steroid-dependent ulcerative colitis: results at 1 year.
    Cabriada JL, Ibargoyen N, Hernández A, Bernal A, Castiella A.
    Dig Liver Dis; 2010 Jun 01; 42(6):432-5. PubMed ID: 19833566
    [Abstract] [Full Text] [Related]

  • 17. Treatment cost of ulcerative colitis is apheresis with Adacolumn cost-effective?
    Panés J, Guilera M, Ginard D, Hinojosa J, González-Carro P, González-Lara V, Varea V, Domènech E, Badia X.
    Dig Liver Dis; 2007 Jul 01; 39(7):617-25. PubMed ID: 17531555
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The Italian Registry of Therapeutic Apheresis: granulocyte-monocyte apheresis in the treatment of inflammatory bowel disease. A multicentric study.
    Passalacqua S, Ferraro PM, Bresci G, D'Ovidio V, Astegiano M, Principi M, Testa R, D'Incà R, Valpiani D, Armuzzi A, Sablich R, Cavallaro F, Costa F, Di Leo V, Colombo E, Santini A, Aratari A, Lecis P, Saladino V, Riegler G, Marco M, Calella F, Ricci C, Guidi ML, Repaci G, Silla M.
    J Clin Apher; 2011 Dec 01; 26(6):332-7. PubMed ID: 22072543
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.